LYLiang Yang

Liang Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Liang Yang has a total of 46 co-authors. Here are the top co-authors by number of shared publications:

  • Jinglan Zhou

    Department of Radiation Center, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, PR China

    3 shared publications
  • Yuheng Shao

    Department of Radiation Center, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, PR China

    3 shared publications
  • Yumeng Zhang

    Department of Radiation Center, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, PR China

    2 shared publications
  • Bin Du

    Department of Pathology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 201204, China

    1 shared publication
  • Chao Li

    Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Clinical and Translational Research Center, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University

    1 shared publication
  • Chenfei Liu

    Department of Biobank, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 201204, China

    1 shared publication

Latest Publications

  • Open Access

    GPR107-EGFR crosstalk promotes ovarian cancer metastasis by regulating IL-6 release via PI3K/AKT/NF-κB signaling pathway

    by Jing Zhao, Xintao Wang, Tiankang Li, Jie Chen, Haiyan Zhu, Liang Yang, Yingchao Liang


  • Open Access

    A tumor-resident bacterium promotes cervical cancer progression through lysoPC-mediated c-Jun/c-Fos activation

    by Chao Li, Han Zhao, Jingjing Wang, Chenfei Liu, Shiqing He, Jingchao Zhou, Liangyu Li, Yiyao Liu, Qingping Wang, Xiaojing Shen, et al.


  • Open Access

    SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2

    by Yumeng Zhang, Yuheng Shao, Xin Li, Dongdong Zhou, Jinglan Zhou, Qin Yan, Wei Gao, Liang Yang

    The enzymes acetyl-CoA acetyltransferase (ACATs) are membrane-bound enzymes that play critical roles in the regulation of cellular cholesterol homeostasis in various tissues. Here, we aim to assess the effect of ACAT2 on lipid accumulation in cervical cancer (CC). ACAT2 expression is enhanced in CC and is closely associated with the immune evasion and clinical progression of CC. Knockdown of ACAT2 expression in CC cells inhibits CC growth, improves survival in tumor-bearing C57BL/6 mice, and enhances anti-tumor immune responses by natural killer and CD8+ T cells. Protein expression of sterol regulatory element-binding transcription factor 2 (SREBF2) is elevated in CC and mediates the transcriptional activation of ACAT2. E3 ubiquitin-protein ligase parkin (PRKN) expression is attenuated in CC, which results in a diminished level of ubiquitination of SREBF2 and enhanced stability of SREBF2. PRKN inhibits cholesterol accumulation in CC, activates mitophagy, and ameliorates immune evasion through inhibition of SREBF2/ACAT2. Overexpression of SREBF2 blocks the anti-tumor effects of PRKN in an ACAT2-dependent manner. The present study underscores the pivotal function of ACAT2 in CC progression and delineates its potential as a therapeutic latent strategy. This approach involves the strategic obstruction of the metabolic pathway associated with ACAT2.


  • Open Access

    Cumulative dose assessment with transformer‐based deformable image registration addition for cervical cancer patients

    by Dongdong Zhou, Yuheng Shao, Fuying Wan, Jiayi Chen, Yumeng Zhang, Jiaqi Feng, Yunfei Ye, Jinglan Zhou, Fubin Zeng, Qi Chen, et al.

    Purpose: Based on the combination mode of internal and external radiotherapy for cervical cancer, this study aimed to investigate an accurate transformer‐based deformable image registration (DIR) method for cumulative dose assessment. Methods and Materials: According to a retrospective analysis conducted on 180 patients with cervical cancer who underwent intracavitary brachytherapy (ICBT) and external beam radiation therapy (EBRT), this study proposed a mix‐transformer structure‐based deformable image registration (MTDIR) network for registering CT scans of ICBT and EBRT, followed by dose accumulation and assessment. The mean dice similarity coefficient (DSC) and Hausdorff distance (HD) of the rectum and bladder were computed to compare the performance of MTDIR with that of the state‐of‐the‐art VoxelMorph method and the DIR method provided by velocity. Additionally, the cumulative dose of the bladder and rectum from four methods was calculated: direct DVH parameter addition (DA), DIR‐based dose addition provided by Velocity (VA), VoxelMorph‐based dose addition (VoA), and MTDIR‐based dose addition (MA). Results: The mean DSC values of MTDIR, VoxelMorph, and Velocity for the bladder were 0.78, 0.75, and 0.72 for the registration between CT scans of EBRT and the last ICBT, respectively. The mean DSC values of the rectum were also equal to 0.58, 0.56, and 0.52. The mean HDmean values of MTDIR, VoxelMorph, and Velocity for the bladder were 4.81, 5.16, and 5.43, and the mean HDmean values of the rectum were 5.41, 5.81, and 6.93, respectively. For the registration between CT scans of ICBT, the mean DSC values of MTDIR, VoxelMorph, and Velocity for the bladder were obtained 0.82, 0.80, and 0.77, and the mean DSC values for the rectum were equal to 0.70, 0.68, and 0.63, respectively. The mean HDmean values of MTDIR, VoxelMorph, and Velocity for the bladder were 4.22, 4.58, and 4.79, and the mean HDmean values of the rectum were obtained 4.86, 5.17, and 5.64, respectively. The results generally suggested that MTDIR outperformed VoxelMorph and Velocity. Conclusions: The study findings demonstrated that the model developed based on parameters obtained from the proposed method exhibited higher registration accuracy.


  • Comprehensive analysis of breast cancer oxidative stress related gene signature: a combination of bulk and single-cell RNA sequencing analysis

    by Yuheng Shao, Yumeng Zhang, Jie Chen, Liang Yang, Meihong Wu, Zhiyuan Fan, Zhigang Zhuang

    Oxidative stress influences the tumor microenvironment, driving breast cancer progression and drug resistance. This study aimed to develop a prognostic gene signature based on oxidative stress-related genes (OSRGs) to assess patient outcomes and immune status. UCSC Xena (http://xena.ucsc.edu/) and GEO (https://www.ncbi.nlm.nih.gov/geo/) databases were used to obtain RNA-seq data and corresponding clinical information. The classification of OSRG subtypes was performed using consensus cluster. The oxidative stress related scoring (OSRS) model was established combining Lasso regression and multivariable Cox regression. The analysis of tumor mutation burden (TMB) and somatic mutation were carried out using the R package ‘maftools’. Python package ‘pySCENIC’ was used to construct and analyze the transcription factor network. Additionally, immune infiltration was analyzed using R packages ‘CIBERSORT’ and ‘ESTIMATE’. Three OSRG subgroups were identified and the Differentially Expressed Genes (DEGs) among them were enriched in humoral immunity, cytokine communication and drug metabolism pathways. OSRS model was established based on the DEGs and revealed association with patients’ overall survival, somatic mutations, immune statuses, and drug resistance. Finally, transcription factor TFAP2B was identified as a key regulatory factor in high OSRS cells, and associated with a negative prognostic outcome in Basal-like breast cancer patients.